Skip to main content

The Evidence Base for Lyme Infection-Associated Chronic Illnesses Treatment

Recently completed

A committee-supported project or activity that has been completed and for which output dissemination has begun. Its committee has been disbanded and closeout procedures are underway.

Lyme disease is the most commonly reported vector-borne disease in the United States. While most cases are effectively treated through oral antibiotics, some patients develop persistent and debilitating symptoms that last months to years despite standard antibiotic treatment. Ticks that spread Lyme disease can also carry other pathogens, leading to potential co-infection and further complicating diagnosis and treatment.

Under the auspices of the National Academies of Sciences, Engineering, and Medicine, an ad hoc committee will conduct a study to assess the current evidence base for treatment of Lyme infection-associated chronic illnesses to identify research priorities and new opportunities.

Featured publication

Consensus

·

2025

Around 10-20% of people who contract Lyme disease, the most common tickborne disease in the U.S., develop persistent, often debilitating symptoms such as chronic pain, fatigue, and cognitive dysfunction. Lyme infection-associated chronic illnesses (IACI) share symptoms common to other IACI such as L...

View details

Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.